SUNEKOS® PERFORMA

INFORMATION

Product Description

Sunekos® Performa Product Overview

Sunekos® Performa is an advanced biorevitalization treatment combining low molecular weight hyaluronic acid (HA) and a patented HY6AA amino acid complex in a unique ratio designed to enhance the longevity and effectiveness of HA. This formulation targets the extracellular matrix (ECM), helping to reduce the signs of aging by stimulating collagen and elastin production. Sunekos® Performa is particularly beneficial for addressing fine lines, wrinkles, and skin laxity across various areas, including the face, periocular region, neck, décolleté, and hands​.

Key Features:

Hyaluronic Acid and Amino Acid Combination: Patented HY6AA formula in a specific ratio that reduces HA degradation by hyaluronidase, enhancing hydration and skin regeneration.
Targeted Areas: Face, neck, décolleté, hands, and periocular regions.
Formulation: Pre-mixed vial with HA and amino acids for easy use and optimal ECM regeneration.
Sunekos® Performa Indications for Use

Sunekos® Performa is designed for skin rejuvenation and biostimulation, especially in patients with signs of aging and skin laxity. It is ideal for treating fine lines, loss of elasticity, and volume reduction in the mid-to-lower face and other high-mobility areas.

Primary Indications:

Fine Lines and Wrinkles: Reduces the appearance of superficial and deep lines.
Skin Firmness and Elasticity: Rejuvenates the ECM, enhancing skin resilience and tone.
Volume Restoration: Provides a subtle volumizing effect in areas of mild skin laxity.
Hydration: Maintains skin moisture, creating a smooth, revitalized look​.
Sunekos® Performa Dosage Information

Sunekos® Performa treatment protocols vary depending on the patient’s specific needs and the targeted areas. The recommended protocol involves a combination of techniques and session frequency tailored to achieve optimal biostimulation and rejuvenation results.

Treatment Protocols:

Face and Periocular Areas:
Session Frequency: Three sessions, with a fourth session optional, depending on the patient’s response.
Interval: Every two weeks.
Technique: Injection using cannula or needle (30-32G) into the mid-to-deep dermis, perpendicular to the skin folds.
Full Face and Neck:
Tools: 25-27G cannula and 30-32G needle.
Volume per Injection: 1 ml syringe recommended, allowing for controlled, even distribution across the treatment area.
Frequency: Every two weeks for three to four sessions.
Additional Areas (Décolleté and Hands):
Frequency: Same protocol as facial areas, depending on the degree of skin aging and laxity.
Application Method: Microinjection techniques focusing on rejuvenation and hydration of thin-skinned areas​.
Sunekos® Performa Side Effects and Precautions

Sunekos® Performa is well-tolerated, with mild side effects typical of injectable treatments. The amino acid and HA composition reduces the likelihood of adverse reactions, as both components are highly biocompatible.

Common Side Effects:

Mild Redness and Swelling: Temporary swelling or redness at injection sites, typically resolving within 24-48 hours.
Bruising: Bruising may occur, especially in sensitive skin areas.
Discomfort: Some patients report minor discomfort during or after the injection, mitigated by the low-molecular-weight HA and amino acid combination.

Precautions:

Aseptic Technique: Essential to prevent infection.
Contraindications: Not suitable for patients with autoimmune diseases, active infections, or known hypersensitivity to hyaluronic acid or amino acids.
Pregnancy and Breastfeeding: Usage is not recommended during pregnancy or breastfeeding due to limited safety data.
Post-Treatment Care: Patients should avoid intensive physical activity and sun exposure for 24 hours post-treatment​.
Sunekos® Performa Clinical Studies or Real-World Outcomes

Clinical studies on Sunekos® Performa show significant results in skin rejuvenation and hydration, with extended effects due to its unique formulation. The innovative ratio of hyaluronic acid to amino acids ensures HA persistence, leading to long-lasting improvements in skin texture and elasticity.

Key Findings:

HA Degradation Reduction: Sunekos® Performa reduces hyaluronidase activity by 40%, allowing HA to maintain hydration effects longer than other formulations.
Improvement in Skin Density and Firmness: In studies, patients experienced 15-30% improvements in skin density and smoothness within 4-6 weeks.
High Patient Satisfaction: 90% of patients reported satisfaction with the treatment, noting visible improvements in skin elasticity and hydration.

Clinical Observations:

Extended HA Action: Sunekos® Performa’s amino acid mix stabilizes HA, creating sustained hydration and a more youthful appearance.
Biostimulation of ECM Components: Significant increases in collagen types IV and VII, elastin, and fibronectin were noted, strengthening skin’s structural integrity and supporting smoother texture.
Studies on 10 Patients: In a safety and efficacy study, all patients showed enhanced skin firmness and texture after a three-session protocol, with effects lasting up to six months post-treatment​.
Sunekos® Performa Composition and Active Ingredients

Sunekos® Performa contains low molecular weight hyaluronic acid combined with the patented HY6AA formula, a mixture of six amino acids (glycine, proline, lysine, leucine, valine, and alanine) chosen for their ability to stimulate ECM components and counteract HA degradation.

Key Ingredients:

Low Molecular Weight Hyaluronic Acid: Promotes hydration and skin elasticity.
HY6AA Amino Acid Complex: This specific amino acid blend aids in reducing HA breakdown while promoting ECM components such as collagen and elastin.
Balanced Ratio of HA and AA: This formula allows Sunekos® Performa to remain active longer, enhancing hydration and structural support for skin rejuvenation​.
Sunekos® Performa Drug Interactions

Sunekos® Performa is safe with minimal systemic absorption, leading to few drug interactions. However, as with any injectable treatment, some considerations are necessary.

Important Considerations:

Immunosuppressive Therapy: Use with caution in patients on immunosuppressive medications due to an elevated risk of infection​.

Concurrent Aesthetic Treatments: Sunekos® Performa may be combined with other biorevitalizing treatments, but a two-week interval is recommended to prevent inflammation.

Anticoagulants: Patients on blood-thinning medications should be informed of a higher likelihood of bruising at injection sites.